The past decade has witnessed significant advances in the systemic treatment of advanced
hepatocellular carcinoma (HCC). Nevertheless, the newly developed treatment strategies …

The world-wide increase in chronic liver disease (CLD) calls for refinement of diagnostic and
prognostic measures for early and accurate disease detection and management …

Abstract This CIRSE Standards of Practice document is aimed at interventional radiologists
and provides best practices for performing transarterial chemoembolisation. It has been …

Background & Aims Hepatocellular nodular lesions (HNLs) constitute a heterogeneous
group of disorders. Differential diagnosis among these lesions, especially high-grade …

Background & Aims We elucidated the clinical and immunologic implications of serum IL-6
levels in patients with unresectable hepatocellular carcinoma (HCC) treated with …

The incidence of hepatocellular carcinoma (HCC) and HCC-related deaths has increased
over the last few decades. There are several risk factors of HCC such as viral hepatitis (B …

Overdiagnosis refers to detection of disease that would not otherwise become clinically
apparent during a patient's lifetime. Overdiagnosis is common and has been reported for …

Background & Aims Microvascular invasion (MVI), a major risk factor for tumor recurrence
after surgery in hepatocellular carcinoma (HCC), is only detectable by microscopic …

Background The early diagnosis of hepatocellular carcinoma (HCC) can greatly improve
patients'5-year survival rate, and the early efficacy assessment is important for oncologists to …

The development of high-performance photoacoustic (PA) probes that can monitor disease
biomarkers in deep tissue has the potential to replace invasive medical procedures such as …